These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 38995780)

  • 1. Early Astrocytic Dysfunction Is Associated with Mistuned Synapses as well as Anxiety and Depressive-Like Behavior in the AppNL-F Mouse Model of Alzheimer's Disease.
    Portal B; Södergren M; Parés I Borrell T; Giraud R; Metzendorf NG; Hultqvist G; Nilsson P; Lindskog M
    J Alzheimers Dis; 2024; 100(3):1017-1037. PubMed ID: 38995780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippocampal disruptions of synaptic and astrocyte metabolism are primary events of early amyloid pathology in the 5xFAD mouse model of Alzheimer's disease.
    Andersen JV; Skotte NH; Christensen SK; Polli FS; Shabani M; Markussen KH; Haukedal H; Westi EW; Diaz-delCastillo M; Sun RC; Kohlmeier KA; Schousboe A; Gentry MS; Tanila H; Freude KK; Aldana BI; Mann M; Waagepetersen HS
    Cell Death Dis; 2021 Oct; 12(11):954. PubMed ID: 34657143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phagocytic clearance of presynaptic dystrophies by reactive astrocytes in Alzheimer's disease.
    Gomez-Arboledas A; Davila JC; Sanchez-Mejias E; Navarro V; Nuñez-Diaz C; Sanchez-Varo R; Sanchez-Mico MV; Trujillo-Estrada L; Fernandez-Valenzuela JJ; Vizuete M; Comella JX; Galea E; Vitorica J; Gutierrez A
    Glia; 2018 Mar; 66(3):637-653. PubMed ID: 29178139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Inflammatory Treatment with FTY720 Starting after Onset of Symptoms Reverses Synaptic Deficits in an AD Mouse Model.
    Kartalou GI; Salgueiro-Pereira AR; Endres T; Lesnikova A; Casarotto P; Pousinha P; Delanoe K; Edelmann E; Castrén E; Gottmann K; Marie H; Lessmann V
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial Alterations in Neurons Derived from the Murine AppNL-F Knock-In Model of Alzheimer's Disease.
    Dentoni G; Naia L; Portal B; Leal NS; Nilsson P; Lindskog M; Ankarcrona M
    J Alzheimers Dis; 2022; 90(2):565-583. PubMed ID: 36155507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairment of Spike-Timing-Dependent Plasticity at Schaffer Collateral-CA1 Synapses in Adult APP/PS1 Mice Depends on Proximity of Aβ Plaques.
    Garad M; Edelmann E; Leßmann V
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics Time-Course Study of App Knock-In Mice Reveals Novel Presymptomatic Aβ42-Induced Pathways to Alzheimer's Disease Pathology.
    Schedin-Weiss S; Nilsson P; Sandebring-Matton A; Axenhus M; Sekiguchi M; Saito T; Winblad B; Saido T; Tjernberg LO
    J Alzheimers Dis; 2020; 75(1):321-335. PubMed ID: 32280097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
    Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
    Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral and neural network abnormalities in human APP transgenic mice resemble those of App knock-in mice and are modulated by familial Alzheimer's disease mutations but not by inhibition of BACE1.
    Johnson ECB; Ho K; Yu GQ; Das M; Sanchez PE; Djukic B; Lopez I; Yu X; Gill M; Zhang W; Paz JT; Palop JJ; Mucke L
    Mol Neurodegener; 2020 Sep; 15(1):53. PubMed ID: 32921309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EphA4 loss improves social memory performance and alters dendritic spine morphology without changes in amyloid pathology in a mouse model of Alzheimer's disease.
    Poppe L; Rué L; Timmers M; Lenaerts A; Storm A; Callaerts-Vegh Z; Courtand G; de Boer A; Smolders S; Van Damme P; Van Den Bosch L; D'Hooge R; De Strooper B; Robberecht W; Lemmens R
    Alzheimers Res Ther; 2019 Dec; 11(1):102. PubMed ID: 31831046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.
    Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
    BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of blunting astrocyte activity on hippocampal synaptic plasticity in a mouse model of early Alzheimer's disease based on amyloid-β peptide exposure.
    Lopes CR; Amaral IM; Pereira MF; Lopes JP; Madeira D; Canas PM; Cunha RA; Agostinho P
    J Neurochem; 2022 Mar; 160(5):556-567. PubMed ID: 35043392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disrupted Maturation of Prefrontal Layer 5 Neuronal Circuits in an Alzheimer's Mouse Model of Amyloid Deposition.
    Chen C; Wei J; Ma X; Xia B; Shakir N; Zhang JK; Zhang L; Cui Y; Ferguson D; Qiu S; Bai F
    Neurosci Bull; 2023 Jun; 39(6):881-892. PubMed ID: 36152121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knock-in models related to Alzheimer's disease: synaptic transmission, plaques and the role of microglia.
    Benitez DP; Jiang S; Wood J; Wang R; Hall CM; Peerboom C; Wong N; Stringer KM; Vitanova KS; Smith VC; Joshi D; Saito T; Saido TC; Hardy J; Hanrieder J; De Strooper B; Salih DA; Tripathi T; Edwards FA; Cummings DM
    Mol Neurodegener; 2021 Jul; 16(1):47. PubMed ID: 34266459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The APP Intracellular Domain Is Required for Normal Synaptic Morphology, Synaptic Plasticity, and Hippocampus-Dependent Behavior.
    Klevanski M; Herrmann U; Weyer SW; Fol R; Cartier N; Wolfer DP; Caldwell JH; Korte M; Müller UC
    J Neurosci; 2015 Dec; 35(49):16018-33. PubMed ID: 26658856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's Disease Risk Factor Pyk2 Mediates Amyloid-β-Induced Synaptic Dysfunction and Loss.
    Salazar SV; Cox TO; Lee S; Brody AH; Chyung AS; Haas LT; Strittmatter SM
    J Neurosci; 2019 Jan; 39(4):758-772. PubMed ID: 30518596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in Synaptic Dysfunction Between rTg4510 and APP/PS1 Mouse Models of Alzheimer's Disease.
    Gelman S; Palma J; Tombaugh G; Ghavami A
    J Alzheimers Dis; 2018; 61(1):195-208. PubMed ID: 29154272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal A2A receptor exacerbates synapse loss and memory deficits in APP/PS1 mice.
    Gomez-Murcia V; Launay A; Carvalho K; Burgard A; Meriaux C; Caillierez R; Eddarkaoui S; Kilinc D; Siedlecki-Wullich D; Besegher M; Bégard S; Thiroux B; Jung M; Nebie O; Wisztorski M; Déglon N; Montmasson C; Bemelmans AP; Hamdane M; Lebouvier T; Vieau D; Fournier I; Buee L; Lévi S; Lopes LV; Boutillier AL; Faivre E; Blum D
    Brain; 2024 Aug; 147(8):2691-2705. PubMed ID: 38964748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid β induces interneuron-specific changes in the hippocampus of APPNL-F mice.
    Sos KE; Mayer MI; Takács VT; Major A; Bardóczi Z; Beres BM; Szeles T; Saito T; Saido TC; Mody I; Freund TF; Nyiri G
    PLoS One; 2020; 15(5):e0233700. PubMed ID: 32469963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.